 1 Agents affecting nervous system and sensory organs
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
212 Antiarrhythmic agents
|
213 Diuretics
|
214 Antihypertensives
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
217 Vasodilators
|
2171 Coronary dilators
|
 D00302 Dipyridamole (JP18/USP/INN)
D00515 Nitroglycerin (JP18/USP)
D00516 Isosorbide dinitrate (JP18/USP/INN)
D00630 Isosorbide mononitrate (JP18/USP/INN)
D02631 Dilazep dihydrochloride hydrate (JP18)
D01220 Trapidil (JP18/INN)
D01810 Nicorandil (JP18/USAN/INN)
D01606 Trimetazidine hydrochloride (JP18)
D00616 Diltiazem hydrochloride (JP18/USP)
D00615 Amlodipine besylate (USP); Amlodipine besilate (JP18)
D00437 Nifedipine (JP18/USP/INN)
D00629 Nitrendipine (JP18/USAN/INN)
D00619 Verapamil hydrochloride (JP18/USP)
|
2172 Peripheral artery dilators
|
2179 Others
|
218 Hyperlipidemia agents
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan